Renascience Inc

NEW
TSE:4889 (Japan)   Ordinary Shares
円 1,230 -76 (-5.82%) Sep 1
At Loss
P/B:
5.23
Market Cap:
円 16.95B ($ 106.02M)
Enterprise V:
円 15.15B ($ 94.76M)
Volume:
385.80K
Avg Vol (2M):
421.23K
Trade In:
Volume:
385.80K
At Loss

Business Description

Renascience Inc

ISIN : JP3981100005

Share Class Description:

TSE:4889: Ordinary Shares

Total Employee Number:

4
Description
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.98
Interest Coverage
No Debt
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
61.99
Distress
Grey
Safe
Beneish M-Score
-2.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
31.49
9-Day RSI
37.65
14-Day RSI
40.29
3-1 Month Momentum %
13.36
6-1 Month Momentum %
-23.69
12-1 Month Momentum %
-29.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
61.96
Quick Ratio
61.96
Cash Ratio
60.29
Days Inventory
0.92
Days Sales Outstanding
175.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-2.7
Shareholder Yield %
-10.22
Name Current Vs Industry Vs History
Gross Margin %
93.66
Operating Margin %
-491.15
Net Margin %
-461.59
EBITDA Margin %
-491.15
FCF Margin %
-424.93
OCF Margin %
-424.93
ROE %
-12.97
ROA %
-12.39
ROIC %
-995.61
3-Year ROIIC %
-139.66
ROC (Joel Greenblatt) %
-936.54
ROCE %
-13.8
Years of Profitability over Past 10-Year
1

Financials

TSE:4889's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Renascience Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 68.554
EPS (TTM) (円) -24.08
Beta -0.141
3-Year Sharpe Ratio 0.6
3-Year Sortino Ratio 2.69
Volatility % 73.12
14-Day RSI 40.29
14-Day ATR (円) 96.555383
20-Day SMA (円) 1334
12-1 Month Momentum % -29.22
52-Week Range (円) 1101 - 2342
Shares Outstanding (Mil) 13.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Renascience Inc Filings

Filing Date Document Date Form
No Filing Data

Renascience Inc Stock Events

Financials Calendars
Event Date Price (円)
No Event Data

Renascience Inc Frequently Asked Questions

What is Renascience Inc(TSE:4889)'s stock price today?
The current price of TSE:4889 is 円1230.00. The 52 week high of TSE:4889 is 円2342.00 and 52 week low is 円1101.00.
When is next earnings date of Renascience Inc(TSE:4889)?
The next earnings date of Renascience Inc(TSE:4889) is .
Does Renascience Inc(TSE:4889) pay dividends? If so, how much?
Renascience Inc(TSE:4889) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Renascience Inc

No articles.